APOBEC3G and glioblastoma: In this study, we screened GICs and TCGA data and found that APOBEC3G was highly expressed in mesenchymal GBM; it was also associated with significantly decreased survival time in GBM patients, suggesting that it is a tumor-promoting factor in GBM.